CN1488368A - Medicine for treating nasitis - Google Patents
Medicine for treating nasitis Download PDFInfo
- Publication number
- CN1488368A CN1488368A CNA021357153A CN02135715A CN1488368A CN 1488368 A CN1488368 A CN 1488368A CN A021357153 A CNA021357153 A CN A021357153A CN 02135715 A CN02135715 A CN 02135715A CN 1488368 A CN1488368 A CN 1488368A
- Authority
- CN
- China
- Prior art keywords
- radix angelicae
- borneolum syntheticum
- angelicae dahuricae
- rhinitis
- moschus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims description 33
- 229940079593 drug Drugs 0.000 title description 8
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims abstract description 25
- 241000566693 Asteriscus Species 0.000 claims abstract description 16
- 206010039083 rhinitis Diseases 0.000 claims description 20
- 241000972155 Moschus Species 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 5
- 238000012856 packing Methods 0.000 claims description 5
- 238000010298 pulverizing process Methods 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 11
- 238000000034 method Methods 0.000 abstract description 4
- 208000024891 symptom Diseases 0.000 abstract description 4
- 239000000843 powder Substances 0.000 abstract description 3
- 208000002193 Pain Diseases 0.000 abstract description 2
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 abstract 1
- 244000061520 Angelica archangelica Species 0.000 abstract 1
- 241000402754 Erythranthe moschata Species 0.000 abstract 1
- 235000001287 Guettarda speciosa Nutrition 0.000 abstract 1
- 241001596954 Larimichthys Species 0.000 abstract 1
- 229940116229 borneol Drugs 0.000 abstract 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 abstract 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 abstract 1
- 230000002708 enhancing effect Effects 0.000 abstract 1
- 206010019233 Headaches Diseases 0.000 description 6
- 231100000869 headache Toxicity 0.000 description 6
- 201000010099 disease Diseases 0.000 description 4
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 4
- 210000003928 nasal cavity Anatomy 0.000 description 3
- 210000001331 nose Anatomy 0.000 description 3
- 229940126701 oral medication Drugs 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 206010020565 Hyperaemia Diseases 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 210000000214 mouth Anatomy 0.000 description 2
- 210000002850 nasal mucosa Anatomy 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 229940127557 pharmaceutical product Drugs 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 206010009137 Chronic sinusitis Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- 206010028748 Nasal obstruction Diseases 0.000 description 1
- 206010039085 Rhinitis allergic Diseases 0.000 description 1
- 201000010105 allergic rhinitis Diseases 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 201000009151 chronic rhinitis Diseases 0.000 description 1
- 208000027157 chronic rhinosinusitis Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000002483 medication Methods 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 210000003097 mucus Anatomy 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000014860 sensory perception of taste Effects 0.000 description 1
- 210000004243 sweat Anatomy 0.000 description 1
- 238000002636 symptomatic treatment Methods 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
Landscapes
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention is a biyanqing, prepared by borneol, Angelica dehurica, Asteriscus Pseudosciaena and musk, little components, simple to process, and low cost. It selects peculiar formula and powdery mode, the usage simple, even to use it, side-effect little, treatment quick and curing rate high. It makes Chinese medicinal powder directly inbreathed to act on symptom surface, largely enhancing the curing effect, and relieving the patient's pain.
Description
What the present invention relates to is the compound method of medicine, more particularly is clear about the rhinitis that is used for the treatment of diseases such as rhinitis, headache.
Usually treatment of diseases method majorities such as the rhinitis known to the people, headache use oral medications, this administering mode is relatively poor to peripheral nerve treatment of diseases effect, medicine is difficult to act on focus, and simultaneously long-term oral medication is very big to the internal organs infringement of human body; For rhinitis the administration of the drop of use is arranged also, though this mode can directly act on focus, its medication inequality, often often medicament flows into the oral cavity, influences the sense of taste.Existing oral medicine or drop especially in medicine, have all that it contains that the Chinese medicine component is many, processed complex, cost be higher, therapeutic effect has tangible deficiency to a certain extent, therefore, does not satisfy using and the treatment demand of patient.
The object of the present invention is to provide and a kind ofly can eliminate above-mentioned shortcoming, the rhinitis of characteristics such as have that the Chinese medicine component is few, processing is simple, with low cost, dosage is few, focus dispenser, curative effect are fast is clear.Especially select the powdery administering mode for use, realized that medication is even, tack good, few side effects, treatment is rapid, cure rate is high, is ideal treatment rhinitis patient's middle pharmaceutical products.
Rhinitis of the present invention is clearly that Borneolum Syntheticum is arranged, the Radix Angelicae Dahuricae, Asteriscus Pseudosciaenae, compositions such as Moschus, it basic composition is Borneolum Syntheticum, the Radix Angelicae Dahuricae, also can add Asteriscus Pseudosciaenae, Moschus etc., it is to prepare according to the component ratio, pulverize, porphyrize, packing is made Chinese patent medicine or Chinese medicine preparation, the described Borneolum Syntheticum that basic composition is, the Radix Angelicae Dahuricae, or Borneolum Syntheticum, the Radix Angelicae Dahuricae, Asteriscus Pseudosciaenae, Moschus, wherein Borneolum Syntheticum is 10-90%, the Radix Angelicae Dahuricae is 10-90%, or Borneolum Syntheticum is 30-60%, the Radix Angelicae Dahuricae is 10-30%, Asteriscus Pseudosciaenae 60-100%, Moschus 1-10%, it is the ratio preparation according to above-mentioned component, pulverize, porphyrize, packing is made Chinese patent medicine or Chinese medicine preparation.According to different patients and different application targets, can prepare different therapeutic schemes, can above-mentioned component is formulated according to following ratio, the component ratio of described Borneolum Syntheticum, the Radix Angelicae Dahuricae is respectively 10-30%, 30-60% is formulated; The component ratio of described Borneolum Syntheticum, the Radix Angelicae Dahuricae is respectively 10-60%, 10-60% is formulated; Described Borneolum Syntheticum is that 30-60%, the Radix Angelicae Dahuricae are that 10-30%, Asteriscus Pseudosciaenae 60-100%, Moschus 1-10% are formulated; Described Borneolum Syntheticum is that 10-60%, the Radix Angelicae Dahuricae are that 10-60%, Asteriscus Pseudosciaenae 30-100%, Moschus 10-60% are formulated.Usually make Chinese patent medicine or Chinese medicine powder according to ratio preparation, pulverizing, porphyrize, the packing of above-mentioned component, suction is released into nasal cavity before medicine can being placed on nose during use, medicine is adsorbed on nasal cavity equably in the process that suction is released, thereby just can carry out symptomatic treatment effectively under few dose.Make the patient reduce the misery of oral medication, avoided the side effect of medication, realized veritably suiting the remedy to the case.Borneolum Syntheticum in the component is the aromatic and inducing resuscitation medicine, its drug effect for have one's ideas straightened out, refreshment, dispel the wind, the effect of pain relieving; The Radix Angelicae Dahuricae is for going into meridians and only have a headache, induce sweat the effect of cold expelling, promoting blood circulation and detumescence; Asteriscus Pseudosciaenae belongs to the Theory of Convergence Classes medicine, and Borneolum Syntheticum and Radix Angelicae Dahuricae compatibility are treated various migraine and general headaches; Borneolum Syntheticum and Asteriscus Pseudosciaenae compatibility sensiblely go pus nasal mucus, antiinflammatory; Borneolum Syntheticum, the Radix Angelicae Dahuricae, Asteriscus Pseudosciaenae three flavor compatibilities, its effect is for having one's ideas straightened out, stuffy nose relieving, convergence, antiinflammatory, decaptitating bitterly.The symptom that common all kinds of rhinitis causes has nasal obstruction, headache, nasal mucosa swelling, hyperemia, pus tears many etc., adjusts the proportioning of mentioned components at these symptoms, can draw eutherapeutic in medicament, the patient that for example has a stuffy nose sucks medicament can be unobstructed after one minute; Headache medication every day 2-3 time can disappear in 24 hours; Symptom medications every day such as nasal mucosa swelling, hyperemia, pus tears are many 2-3 time just can reach ideal curative effect in 10-15 days.By clinical trial, be 100% to all kinds of rhinitis effective percentage, the allergic rhinitis cure rate is 75%, chronic rhinitis and sinusitis cure rate are 50%.
Rhinitis removing summer-heat of the present invention has been determined, and the oral dose of rhinitis patient is big for a long time, cure rate is low, drop pollutes oral cavity, the unequal problem of medication, have the Chinese medicine component few, processing simple, with low cost, characteristics such as dosage is few, good effect, especially select unique middle reagent combination and powdery administering mode for use, realized that usage is simple, medication evenly, few side effects, treatment is rapid, cure rate is high, be specially adapted to more than 3 years old to adult patient, for anemia of pregnant woman, the careful usefulness of infant.It is Chinese medicine powder to be placed on directly suck nasal cavity under the nostril, acts on the disease surface, has improved therapeutic effect widely, has alleviated patient's misery, is present ideal treatment rhinitis patient's middle pharmaceutical products and first-selected Therapeutic Method.
Claims (6)
1, a kind of rhinitis is clear, it is characterized in that being made up of Borneolum Syntheticum, the Radix Angelicae Dahuricae, Asteriscus Pseudosciaenae, Moschus, and it basic composition is Borneolum Syntheticum, the Radix Angelicae Dahuricae, also can add Asteriscus Pseudosciaenae, Moschus, it is to make Chinese patent medicine or Chinese medicine preparation according to the preparation of component ratio, pulverizing, porphyrize, packing.
2, rhinitis as claimed in claim 1 is clear, it is characterized in that it being described Borneolum Syntheticum, the Radix Angelicae Dahuricae of basic composition is, or Borneolum Syntheticum, the Radix Angelicae Dahuricae, Asteriscus Pseudosciaenae, Moschus, wherein Borneolum Syntheticum is that 10-90%, the Radix Angelicae Dahuricae are 10-90%, or Borneolum Syntheticum is that 30-60%, the Radix Angelicae Dahuricae are 10-30%, Asteriscus Pseudosciaenae 60-100%, Moschus 1-10%, and it is to make Chinese patent medicine or middle medicament according to ratio preparation, pulverizing, porphyrize, the packing of above-mentioned component.
3, rhinitis as claimed in claim 1 is clear, it is characterized in that the component ratio of described Borneolum Syntheticum, the Radix Angelicae Dahuricae is respectively 10-30%, 30-60% is formulated.
4, rhinitis as claimed in claim 1 is clear, it is characterized in that the component ratio of described Borneolum Syntheticum, the Radix Angelicae Dahuricae is respectively 10-60%, 10-60% is formulated.
5, rhinitis as claimed in claim 1 is clear, it is characterized in that described Borneolum Syntheticum is that 30-60%, the Radix Angelicae Dahuricae are that 10-30%, Asteriscus Pseudosciaenae 60-100%, Moschus 1-10% are formulated.
6, rhinitis as claimed in claim 1 is clear, it is characterized in that described or Borneolum Syntheticum is that 10-60%, the Radix Angelicae Dahuricae are that 10-60%, Asteriscus Pseudosciaenae 30-100%, Moschus 10-60% are formulated.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA021357153A CN1488368A (en) | 2002-10-09 | 2002-10-09 | Medicine for treating nasitis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNA021357153A CN1488368A (en) | 2002-10-09 | 2002-10-09 | Medicine for treating nasitis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN1488368A true CN1488368A (en) | 2004-04-14 |
Family
ID=34146245
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNA021357153A Pending CN1488368A (en) | 2002-10-09 | 2002-10-09 | Medicine for treating nasitis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN1488368A (en) |
Cited By (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102641327A (en) * | 2012-05-22 | 2012-08-22 | 常端义 | Traditional Chinese medicine ointment for treating rhinosinusitis |
| CN103479784A (en) * | 2013-09-10 | 2014-01-01 | 姚自功 | Medicine for treating rhinitis |
| CN104027542A (en) * | 2014-06-27 | 2014-09-10 | 陈建福 | Liniment for nasal disease |
| CN104940297A (en) * | 2015-05-26 | 2015-09-30 | 昆明理工大学 | Traditional Chinese medicine anti-inflammatory preparation for nasal cavity and preparation method of traditional Chinese medicine anti-inflammatory preparation |
| CN107693655A (en) * | 2017-11-27 | 2018-02-16 | 张肖文 | A kind of Chinese medicine for treating rhinitis composition and preparation method thereof |
| CN111329926A (en) * | 2020-03-25 | 2020-06-26 | 程芸 | Combination medicine for treating rhinitis by using intranasal suppository and preparation method thereof |
| CN117064963A (en) * | 2022-05-09 | 2023-11-17 | 南京铨晶科技开发有限公司 | A traditional Chinese medicine formula preparation for treating rhinitis and its processing method |
-
2002
- 2002-10-09 CN CNA021357153A patent/CN1488368A/en active Pending
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102641327A (en) * | 2012-05-22 | 2012-08-22 | 常端义 | Traditional Chinese medicine ointment for treating rhinosinusitis |
| CN102641327B (en) * | 2012-05-22 | 2013-08-14 | 常端义 | Traditional Chinese medicine ointment for treating rhinosinusitis |
| CN103479784A (en) * | 2013-09-10 | 2014-01-01 | 姚自功 | Medicine for treating rhinitis |
| CN104027542A (en) * | 2014-06-27 | 2014-09-10 | 陈建福 | Liniment for nasal disease |
| CN104940297A (en) * | 2015-05-26 | 2015-09-30 | 昆明理工大学 | Traditional Chinese medicine anti-inflammatory preparation for nasal cavity and preparation method of traditional Chinese medicine anti-inflammatory preparation |
| CN104940297B (en) * | 2015-05-26 | 2018-08-10 | 昆明理工大学 | A kind of Chinese medicine nasal cavity anti-inflammatory preparation and preparation method thereof |
| CN107693655A (en) * | 2017-11-27 | 2018-02-16 | 张肖文 | A kind of Chinese medicine for treating rhinitis composition and preparation method thereof |
| CN111329926A (en) * | 2020-03-25 | 2020-06-26 | 程芸 | Combination medicine for treating rhinitis by using intranasal suppository and preparation method thereof |
| CN117064963A (en) * | 2022-05-09 | 2023-11-17 | 南京铨晶科技开发有限公司 | A traditional Chinese medicine formula preparation for treating rhinitis and its processing method |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102247541A (en) | Medicament for treating hepatorenal disease, diabete, asthma, rheumatism, and dermatoma | |
| CN104352587B (en) | A kind of ointment for treating rhinitis | |
| CN1488368A (en) | Medicine for treating nasitis | |
| CN103223076B (en) | Oral Chinese medicine for treating fractures | |
| CN102078472A (en) | Medicament for treating verruca wart | |
| CN1225281C (en) | Medicine for treating nasosinusitis | |
| CN100584360C (en) | A kind of traditional Chinese medicine composition for treating stomatitis | |
| CN1201769C (en) | Medicine for treating diabetes, nephropathy | |
| CN1164291C (en) | Chinese proprietary for treating protrusion of lumber interverterbral disc and its prepn. | |
| CN108339039B (en) | Chinese medicine for treating bone injury | |
| CN103933476B (en) | It is a kind of to treat pharmaceutical composition of intercostal neuralgia and its production and use | |
| CN102343037A (en) | Drug with effects of bacterium resistance, disinfection, blood circulation promotion, blood stasis removal, immunity improvement, life prolonging and aging delay | |
| CN102343042A (en) | Medicine for treating cardiovascular diseases of hypertension, cardiopathy and cerebral thrombus | |
| WO2012129957A1 (en) | Several pharmaceutical formulations | |
| CN117503846A (en) | A kind of traditional Chinese medicine for treating hemorrhoids and preparation method thereof | |
| CN117064963A (en) | A traditional Chinese medicine formula preparation for treating rhinitis and its processing method | |
| CN105770747A (en) | Traditional Chinese medicine preparation for treating prosopalgia | |
| CN101569735B (en) | Traditional Chinese medicine for treating chronic superficial gastric, digestive ulcer | |
| CN101979046A (en) | Medicament for treating tonsillitis | |
| CN102697831A (en) | External Chinese medicinal composition for treating nasosinusitis and preparation method of composition | |
| CN118178515A (en) | A Chinese medicine composition for treating chemotherapy-induced peripheral neuropathy, and its preparation and application | |
| CN1255132C (en) | Nasosinusitis treating medicine and its preparing process | |
| CN100444855C (en) | A medicinal powder for oral administration for treating diarrhea | |
| CN113491739A (en) | Pain-relieving and stasis-eliminating traditional Chinese medicine for treating endometriosis and preparation method thereof | |
| CN112370518A (en) | Medicine for treating hyperplasia of mammary glands and preparation method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication | ||
| CI01 | Correction of invention patent gazette |
Correction item: deemed to have been withdrawn Correct: delete False: Wrong announcement Number: 34 Volume: 23 |
|
| ERR | Gazette correction |
Free format text: CORRECT: DEEMED WITHDRAWAL; FROM: WRONG PUBLICATION TO: DELETION |
|
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |